Cotinga Pharmaceuticals Inc.
COTQF
$0.0001
$0.000.00%
OTC PK
| 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | 01/31/2019 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 109.50K | -- | 125.80K | 104.50K | 53.00K |
| Gross Profit | -109.50K | -- | -125.80K | -104.50K | -53.00K |
| SG&A Expenses | 248.20K | 251.00K | 256.60K | 444.40K | 214.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 357.80K | 370.80K | 382.30K | 549.00K | 267.00K |
| Operating Income | -357.80K | -370.80K | -382.30K | -549.00K | -267.00K |
| Income Before Tax | -405.40K | -405.60K | -396.70K | -706.70K | -210.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -405.40K | -405.60K | -396.70K | -706.70K | -210.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -405.40K | -405.60K | -396.70K | -706.70K | -210.10K |
| EBIT | -357.80K | -370.80K | -382.30K | -549.00K | -267.00K |
| EBITDA | -345.30K | -358.40K | -369.60K | -532.20K | -246.50K |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 21.99M | 21.99M | 21.99M | 22.22M | 21.99M |
| Average Diluted Shares Outstanding | 21.99M | 21.99M | 21.99M | 22.22M | 21.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |